drugset / Press release
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
2025-12-07 · Molecular Partners AG · original molecularpartners.com ↗
PDF Version 238 KB
The release as fetched from its publisher. molecularpartners.com ↗